FR2851769B1 - NOVEL LXRs RECEPTOR-MODULATING LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS - Google Patents
NOVEL LXRs RECEPTOR-MODULATING LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICSInfo
- Publication number
- FR2851769B1 FR2851769B1 FR0302478A FR0302478A FR2851769B1 FR 2851769 B1 FR2851769 B1 FR 2851769B1 FR 0302478 A FR0302478 A FR 0302478A FR 0302478 A FR0302478 A FR 0302478A FR 2851769 B1 FR2851769 B1 FR 2851769B1
- Authority
- FR
- France
- Prior art keywords
- lxrs
- cosmetics
- receptor
- novel
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0302478A FR2851769B1 (en) | 2003-02-28 | 2003-02-28 | NOVEL LXRs RECEPTOR-MODULATING LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS |
| CA002512886A CA2512886A1 (en) | 2003-02-28 | 2004-02-19 | Ligands that modulate lxr-type receptors |
| EP04712564A EP1599447A1 (en) | 2003-02-28 | 2004-02-19 | Ligands that modulate lxr-type receptors |
| PCT/EP2004/002396 WO2004076418A1 (en) | 2003-02-28 | 2004-02-19 | Ligands that modulate lxr-type receptors |
| ARP040100599A AR043399A1 (en) | 2003-02-28 | 2004-02-26 | MODULATING LIGANDS OF LXRS TYPE RECEIVERS, THEIR PREPARATION PROCEDURE AND ITS USE IN HUMAN MEDICINE, AS WELL AS ALSO IN COSMETICS |
| US11/212,714 US20060058351A1 (en) | 2003-02-28 | 2005-08-29 | Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0302478A FR2851769B1 (en) | 2003-02-28 | 2003-02-28 | NOVEL LXRs RECEPTOR-MODULATING LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2851769A1 FR2851769A1 (en) | 2004-09-03 |
| FR2851769B1 true FR2851769B1 (en) | 2006-06-23 |
Family
ID=32843070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0302478A Expired - Fee Related FR2851769B1 (en) | 2003-02-28 | 2003-02-28 | NOVEL LXRs RECEPTOR-MODULATING LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR043399A1 (en) |
| FR (1) | FR2851769B1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003505435A (en) * | 1999-06-04 | 2003-02-12 | メルク エンド カムパニー インコーポレーテッド | Substituted piperidines as melanocortin-4 receptor gonists |
| WO2002040458A1 (en) * | 2000-11-17 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Isoxazole derivatives |
| CA2438272A1 (en) * | 2001-03-02 | 2002-10-10 | John Macor | Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
-
2003
- 2003-02-28 FR FR0302478A patent/FR2851769B1/en not_active Expired - Fee Related
-
2004
- 2004-02-26 AR ARP040100599A patent/AR043399A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR043399A1 (en) | 2005-07-27 |
| FR2851769A1 (en) | 2004-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60313597D1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS | |
| EP1651195A4 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| CA2431565A1 (en) | Pharmaceutical compositions based on anticholinergics and ciclesonide | |
| FR2937972B1 (en) | OXOAZETIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2937973B1 (en) | MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| ATE409176T1 (en) | 1-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| ATE516037T1 (en) | TOPICAL FORMULATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISEASES | |
| DE60232400D1 (en) | MEANS TO RELIEVE SKIN IRRITATION | |
| IS7491A (en) | Benzoxazinone-derived compounds, their preparation and use as drugs | |
| FR2880020B1 (en) | NEW MODULATORY LIGANDS OF RAR RECEPTORS, USE IN HUMAN MEDICINE AND COSMETICS | |
| HUP0501189A2 (en) | Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain | |
| FR2935380B1 (en) | NOVEL HEXAFLUORO-2-BIPHENYL-ISOPROPANOL COMPOUNDS, MODULATORS OF LXRS-TYPE RECEPTORS, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS IN HUMAN OR VETERINARY MEDICINE AS WELL AS IN COSMETICS. | |
| DK1643999T3 (en) | Pyridoxamine for use in the treatment of diabetic nephropathy in type 2 diabetes | |
| FR2861069B1 (en) | NOVEL RAR RECEPTOR ACTIVATOR LIGANDS, USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2779720B1 (en) | NOVEL DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETOLOGY | |
| FR2917089B1 (en) | NOVEL 4-HETEROARYL-IMIDAZOLE-2-THIONES AS INHIBITORS OF TYROSINASE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2917087B1 (en) | NOVEL 4-PHENYL-IMIDAZOLE-2-THIONES AS INHIBITORS OF TYROSINASE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2851769B1 (en) | NOVEL LXRs RECEPTOR-MODULATING LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2863266B1 (en) | NEW RAR RECEPTOR ACTIVATOR LIGANDS, USE IN HUMAN MEDICINES AND COSMETICS | |
| FR2836683B1 (en) | NOVEL PPARy RECEPTOR ACTIVATION LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2863267B1 (en) | NEW RAR RECEPTOR ACTIVATOR LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2840300B1 (en) | NOVEL RIG RECEPTOR INHIBITOR LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND IN COSMETICS | |
| FR2874502B1 (en) | NOVEL PLANT EXTRACT, PROCESS FOR OBTAINING SAME, AND PHARMACEUTICAL, NUTRACEUTICAL OR COSMETIC APPLICATIONS THEREOF | |
| FR2847255B1 (en) | NOVEL RAY RECEPTOR ANTAGONIST LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
| FR2840299B1 (en) | NEW RAR RECEPTOR INHIBITOR LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CA | Change of address | ||
| ST | Notification of lapse |
Effective date: 20101029 |